{
    "ticker": "BNGO",
    "name": "Bionano Genomics, Inc.",
    "description": "Bionano Genomics, Inc. is a biotechnology company focused on advancing the field of genomics and transforming the way genetic diseases are diagnosed and treated. Founded in 2003 and headquartered in San Diego, California, Bionano is at the forefront of genome analysis technology with its proprietary Saphyr system. This system utilizes optical mapping technology to provide a comprehensive view of the genome, offering researchers and clinicians insights into structural variations that traditional sequencing methods may miss. Bionano's mission is to improve patient outcomes through the discovery of genomic information that can lead to better diagnostics and personalized treatment plans. The company serves various markets, including clinical diagnostics, research institutions, and pharmaceutical companies, and is dedicated to enhancing scientific understanding of genetic conditions. Bionano is also actively involved in collaborations and partnerships aimed at expanding the application of its technology in oncology and genetic disorders, thereby paving the way for improved therapeutic options. With a strong commitment to innovation, Bionano Genomics is well-positioned to play a significant role in the future of genomics and personalized medicine.",
    "industry": [
        "Biotechnology",
        "Genomics"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2003",
    "website": "https://www.bionanogenomics.com",
    "ceo": "Erik Holmlin",
    "social_media": {
        "twitter": "https://twitter.com/BionanoGenomics",
        "linkedin": "https://www.linkedin.com/company/bionano-genomics/"
    },
    "investor_relations": "https://investors.bionanogenomics.com",
    "key_executives": [
        {
            "name": "Erik Holmlin",
            "position": "CEO"
        },
        {
            "name": "C. Mark Kester",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Genomic Analysis",
            "products": [
                "Saphyr System",
                "Saphyr Software"
            ]
        }
    ],
    "seo": {
        "meta_title": "Bionano Genomics, Inc. | Advancing Genomic Analysis Technology",
        "meta_description": "Explore Bionano Genomics, Inc., a leader in genome analysis technology with the Saphyr system, improving diagnostics and patient outcomes in genomics.",
        "keywords": [
            "Bionano Genomics",
            "Genomics",
            "Biotechnology",
            "Saphyr System",
            "Genome Analysis"
        ]
    },
    "faq": [
        {
            "question": "What is Bionano Genomics known for?",
            "answer": "Bionano Genomics is known for its innovative Saphyr system that provides advanced genomic analysis using optical mapping technology."
        },
        {
            "question": "Who is the CEO of Bionano Genomics?",
            "answer": "Erik Holmlin is the CEO of Bionano Genomics, Inc."
        },
        {
            "question": "Where is Bionano Genomics headquartered?",
            "answer": "Bionano Genomics is headquartered in San Diego, California, USA."
        },
        {
            "question": "What are Bionano Genomics' main products?",
            "answer": "Bionano Genomics' main products include the Saphyr system and Saphyr software for genomic analysis."
        },
        {
            "question": "When was Bionano Genomics founded?",
            "answer": "Bionano Genomics was founded in 2003."
        }
    ],
    "competitors": [
        "ILMN",
        "PACB",
        "NVTA",
        "EDIT"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "MRNA",
        "REGN"
    ]
}